Wall Street looks to extend its winning streak ahead of the CPI report

Register now for FREE unlimited access to Reuters.com

  • Headline CPI seen easing Tuesday
  • Bristol Myers rises on FDA approval for psoriasis drug
  • Twitter says Musk’s latest attempt to scrap deal invalid
  • Indexes up: Dow 0.66%, S&P 0.97%, Nasdaq 1.14%

NEW YORK, Sept 12 (Reuters) – Wall Street advanced to two-week highs on Monday with few impediments to thwart a three-day winning streak as investors awaited crucial inflation data.

All three major US stock indexes appeared set to notch their fourth straight session of gains in a broad rally which equally favored growth (.IGX) and value (.IVX) stocks.

“There are no real catalysts today to my knowledge,” said Peter Tuz, president of Chase Investment Counsel in Charlottesville, Virginia. “I thought the market would be flat to down, because there’s a lot riding on CPI.”

Register now for FREE unlimited access to Reuters.com

The Labor Department’s consumer price index (CPI), expected before Tuesday’s opening bell, is this week’s main event, and will be scrutinized for any clues regarding the length and severity of the Federal Reserve’s policy tightening phase.

On Thursday, Fed Chair Jerome Powell affirmed the central bank remains “strongly committed” to tackling decades-high inflation, and that they would “keep at it until the job is done.” read more

Economists polled by Reuters expect monthly CPI to have contracted 0.1% in August, edging down to 8.1% year-on-year, mainly due to the recent cool-down of commodity prices. read more

Financial markets have currently priced in a 92% probability that the Federal Open Markets Committee (FOMC) will implement its third straight 75-basis-point interest rate hike at the conclusion of next week’s policy meeting, according to CME’s FedWatch tool.

“(The market has) pretty much got a 75 basis-point (interest) rate hike baked in,” Tuz added. “It would take a monumental event to swing that up or down.”

The Dow Jones Industrial Average (.DJI) rose 212.19 points, or 0.66%, to 32,363.9, the S&P 500 (.SPX) gained 39.58 points, or 0.97%, to 4,106.94 and the Nasdaq Composite (.IXIC) added 137.49 points, or 1.14%, two 12,249.80.

All 11 major sectors of the S&P 500 were green, with tech (.SPLRCT) enjoying the biggest percentage gain, followed by energy companies (.SPNY).

Economically sensitive transports (.DJT) were outperforming the broader market.

Shares of Apple Inc (AAPL.O), beaten up this year, jumped 4.2% days after the gadget maker unveiled updates to its iPhone and Apple Watch. read more

Drugmaker Bristol-Myers Squibb (BMY.N) surged 4.9% following the Food and Drug Administration’s approval of its psoriasis drug late on Friday.

Rival Amgen Inc ( AMGN.O ), maker of psoriasis drug Otezla, dropped 3.6%.

Twitter Inc slipped 2.0% amid its legal wrangling against Tesla Inc (TSLA.O) chief Elon Musk for scrapping a deal to acquire the social media platform. read more

KFC and Pizza hut operator Yum Brands Inc (YUM.N) advanced 1.0% in the wake of its $2 billion share buyback announcement.

Car selling platform Carvana Co (CVNA.N) jumped 13.1% higher following Piper Sandler’s upgrade of the stock to “overweight.”

Advancing issues outnumbered declining ones on the NYSE by a 3.73-to-1 ratio; on Nasdaq, a 1.93-to-1 ratio favored advancers.

The S&P 500 posted 11 new 52-week highs and no new lows; the Nasdaq Composite recorded 33 new highs and 52 new lows.

Register now for FREE unlimited access to Reuters.com

Reporting by Stephen Culp in New York Editing by Matthew Lewis

Our Standards: The Thomson Reuters Trust Principles.

Leave a Reply

Your email address will not be published. Required fields are marked *